Abstract:People w ith type 1 diabetes require frequent adjustm entoftheirinsulin dose to m aintain as near norm al glycem ia as possible. T his process is not only burdensom e,but for m any di cult to achieve.As a result,controlalgorithm s to facilitate the insulin dosage have been proposed, but have not been com pletely successful in norm alizing glycem ia. Here we present a novel run-to-run control algorithm to adjust the m ealrelated insulin dose using only postprandialblood glucose m easurem ents.
INT R ODUC T ION
T he Expert C om m ittee on the Diagnosis and C lassification ofDiabetes Mellitus (2003) defines diabetes m ellitus asa group ofm etabolic diseases w hich are characterized by hyperglycem ia. T his hyperglycem ia results from defects in insulin secretion,insulin action,or both.Type 1 diabetes is caused by an absolute deficiency of insulin secretion. It includes cases prim arily due to β cell destruction, and w ho are prone to ketoacidosis. T hese cases are those attributable to an autoim m une process,as wellas those w ith β cell destruction for w hich no pathogenesis is know n (i.e.idiopathic).People w ith type 1 diabetesfully depend on exogenous insulin.It is estim ated that 17.1 m illion peopleworld w idehad type1 diabetes in 2000 (Wild et al.,2004; Eiselein et al.,2004) .
T he e cacy of intensive treatm ent in preventing diabetic com plications has been established by the D iabetes C ontroland C om plications Trial (DC C T ) (Diabetes C ontrol and C om plications Trials R esearch Group, 1993) and the United Kingdom Prospective Diabetes Study (UKPDS) (UK Prospective D iabetes Study Group, 1998) . In both trials the treatm ent regim ens that reduced average glycosylated hem oglobin (a clinical m easure of glycem ic control,w hich reflects average blood glucose levels over the preceding 2-3 m onths)A 1C to approxim ately 7% (norm alrange is4-6% )w ere associated w ith fewerlong term m icrovascular com plications. R ecent evidence even suggests thatthese targetlevels m ightnotbe low enough (Khaw et al.,2001) .
Intensive treatm ent requires m ultiple (3 or m ore) daily injections of insulin, or treatm ent w ith an insulin infusion pum p. In any case, this tight control( i.e. asclose to norm alaspossible)should be m aintained for life in order to accrue the full benefits.M any factors influence the insulin dose requirem entsovertim e,including weight,physical condition and stress levels.Due to this,frequent blood glucose m onitoring is required. B ased on these m easurem ents the insulin dosage m ust be m odified, dietary changes im plem ented (such as alteration in the tim ing, frequency and content of the m eals),as wellas changes in activity and exerci se patterns.
With the advent of hom e blood glucose m onitoring technologiesbecom ing available,physicians started to seek ways to use this inform ation to fine-tune the therapeutic regim en. Am ong the first heuristic algorithm s in the literature,we can highlight those of Skyler et al. (1981) and Jovanovic and Peterson (1982) . B oth set heuristic rules based on practicalexperience;the m ain difference between these two is that Skyler et al. (1981) relies on pre-prandialblood glucose m easurem entsexclusively,w hile Jovanovic and Peterson (1982) uses prandialm easurem ents as w ellto adjust the insulin dosing.
T he algorithm proposed by Jovanovic and Peterson (1982) is taken as the basis to program a pocketcom puter,w hich w astested in 5 type1 diabetic subjects.T hey dem onstrate thatcom puterassisted insulin-delivery decision m aking is feasible (C hanochet al., 1985) . T his com puter program was then com pared to the standard approach for new continuous subcutaneous insulin i nfusi on pum p users. Petersonet al. (1986) found the approach to be f easible, although it did not fully norm alize blood glucose levels. Still, computer users achieved low er average blood glucose and A 1C values over the course ofthe study. Schi rinet al. (1985) program m ed a portable com puter to adjust dosing of short and interm ediate acting insulin in a 2-injection perday strategy, using pre-prandial blood glucose m easurem ents. Even w ithin the lim itations of the therapy regim en used,they saw m arked im provem ents in glycem ic control w hen using the com puter. C hiarelli et al. (1990) com pared this com puter m ethod w ith a m anualm ethod;w hile they found no di erencesin glycem ic control,they did notice few er instances ofhypoglycem ia in the com puter users. Peters et al. (1991) adapts this algorithm and com pared its e ectiveness against m anual adjustm ents, finding that m etabolic control and safety were com parable in both.
Taking the heuristic algorithm of Skyler et al. (1981) as their starting point, B eyer et al. (1990) create their ow n algorithm s;as the original,they use pre-prandialblood glucose m easurem ents.In a clinical trial of 50 subjects they clearly show thatthecom putergroup did m uch betterthan the regular intensive treatm ent group (Schrezenm eir et al.,2002) .
So far,none of these com puter algorithm s m ake use ofthe newerm onom eri c i nsul i ns. O wens et al. (2005) propose a run-to-run controlalgorithm to adjustthe tim ing and dose ofm ealrelated insulin boluses,taking advantage ofthese fast acting insulin form ulations.T he basic assum ption is that there is a sensor available from w hich frequent blood glucose m easurem ents can be taken, and thus the m axim um and m inim um blood glucose excursions in the prandial period can be determ ined.T he feasibility ofthe algorithm was studied in a clinicalsetting,m aking som e changes to allow for fingerstick blood glucose determ inations at 60 and 90 m inutes after the start ofthe m eal, in lieu ofthem axim um and m inim um .T wo-thirds of the subjects m aintained acceptable glycem ic control, but the rest diverged in their responses due to various factors (Zisser et al.,2005) .
In thiswork we m odify the algorithm to overcom e the di culties encountered in clinical practice. T he run-to-run form ulation described here gives m ore flexibility to the subject, as blood glucose m easurem ents are not required to be taken at specific tim es.In section 2 we presentthe basisof the run-to-run algorithm ,followed by the specific im plem entation for insulin dosing. W e present sim ulation results using this m ethod in section 3.
R UN-T O-R UN ALGOR IT HM
T he originalform ulation for the run-to-run controlapplied to insulin bolus dosing and tim ing is described in (Owens et al.,2005) .It is based on the application ofa constraint controlschem e in the run-to-run fram ework to optim ize the operation ofbatch processes in the chem icalindustry (Srinivasan et al.,2003a; Srinivasan et al.,2003b) .
T he generalrun-to-run controlalgorithm is:
(1) Param eterize the input profile for run k, u k (t), as U (t, ν k ). Also consider a sam pled versi on,ψ k , of the output y k (t), such that it has the sam e dim ension as the controlled variable vector ν k .T hus we have
(2) C hoose an initialguess for ν k (w henk = 1).
(3) C om plete the run using the input u k (t) corresponding toν k . Determ ineψ k from the m easurem entsy k (t). (4) Update the input param eters as
w here K is an appropriate gain m atrix and ψ r represents the reference values to be attained. Increm ent k for the next run, and repeat steps 3-4 untilconvergence.
In the context of diabetes m anagem ent, w e use the natural day-to-day cycle as a run; w ithin this run,there are three separate m eals (nam ely breakfast,lunch and dinner),for w hich an appropriate insulin bolus has to be determ ined. T he objective is to m inim ize the prandial glycem ic excursion,w ithout overdosing insulin.T hus,our m anipulated variable, u k (t), corresponds to the insulin profile,and them easurem entprofile, y k (t), corresponds to glucose m easurem ents.T im e, t,is w ithin a given day, k,w hich is also a run. Owens et al. (2005) show , using an R GA analysis, that there ise ectively no coupling between the m eals; we also use thisassum ption in the new algorithm .
T here were two draw backs to the originalim plem entation w hen evaluated in a clinical setting. T he first was the changing of the tim ing of the insulin bolusw ith respectto the startofthe m eal. Many tim esthisresulted in a bolusbeing adm inistered in the m iddle ofa m eal;at other tim es,the adm inistration before the start of the m eal w as inconvenient to the subject,and was not adhered to. B esides, w hen using m onom eric insulin, the tim ing of the bolus m akes a negligible di erence in the postprandial profile w hen com pared w ith the e ect of the dose. For these reasons it was decided to fix the tim ing to always coincide w ith the beginning ofthe m eal.T he second draw back was the need for blood glucose determ inations at 60 and 90 m inutes after the start of the m eal;if thesubjectforsom e reason forgotto take eitherof them ,then the algorithm was not able to correct for the follow ing day (Zisser et al.,2005) .
T he m ain change is in the selection of the perform ance m easure used.To have the flexibility of taking blood glucose m easurem ents at di erent tim es,we can no longer use a fixed glucose level. Instead, we use an approxim ation of the slope of the glycem ic response. T he only restrictions we place on the patient is that the first glucose m easurem ent m ust be taken at least 60 m inutes after the startofthe m eal,and the second one be at least 30 m inutes after the first,but not m ore than 180 m inutes after the start ofthe m eal.W e denote these tim es,for each m eal, as:
As the tim es can change from one m eal to the next, and from run to run, we need a reference value thatis norm alized w ith respectto tim e.W e define this reference in term s of units of glucose per m inute for each m eal, ψ r 0 ,and then scale by the actual tim e between the two m easurem ents. W e can w rite this as
w here denotes the Hadam ard (elem ent-w ise) product.
T he m anipulated variable ν k is sim ply the dose of insulin corresponding to each m eal of day k,
.T hecontrollergain, K isset depending on theinsulin sensitivity ofthepatient.
T he reasoning for this perform ance m easure is based on the bl ood gl ucose response seen for di erentdoses.Fora bol usthati scorrectl y dosed, w e expectthe peak glucose excursion to be around 60 m inutes, and to drop from that point on until it reaches the basal level. If the bolus is under-dosed,thism ovesthe peak into the future. T hus,ifwe have under-bolused,the di erence in blood glucose levels between the first and second m easurem ents w ill be negative, or positive but very sm all.Asthe dose approachesthe ideallevel, this di erence w illincrease.T his is allillustrated in figure 1(a) .
SIM ULAT ION R ESULT S
T here are severalpubl i shed m odel sofgl ucose and insulin dynam icsin the literature.Forthisparticular study we have selected the one published by Hovorka et al. (2004) ,replacing the subcutaneous insulin infusion m odelw ith the one described in (Wilinska et al., 2005) . T he m odel captures not only the dynam icsofglucose and insulin,butalso the absorption ofinsulin from a subcutaneousdelivery (asisthe case w ith insulin infusion pum ps), and the appearance of glucose in plasm a from a m ixed m eal.
For each day, the sim ulation has the m eals at 8:00,12:00 and 18:00 hours,w ith a carbohydrate content of 20, 40 and 70 gram s, respectively. For each day and m eal,the tim epoints at w hich blood glucosem easurem entsaretaken areselected random ly (using a uniform distribution);the first one can take place from 60 to 90 m inutesaf terthe start ofthe m eal,the second one follow s 30 to 60 m inutes later. am ount of the insulin bolus is rounded to the nearest 0.1 U of insulin, w hich is the resolution ofm ost infusion pum ps.
T he initial guess for the insulin requirem ent for each m eal is set at an insulin to carbohydrate ratio of 1:33 (a m ore typical value is around 1:10).T huswe startgiving m uch lessinsulin than is actually required for the first run ( k = 0). Figure 1(b) show s the sim ulation for 25 days, w ith figure 1(a) highlighting a couple of days only. T he dotted lines show the desired bounds forthe blood glucose excursions;note thatwe are m ore aggressive in keeping blood glucose below 150 m g/dlthan preventing itfrom going below 70 m g/dl.
Even though the algorithm does not directly considerthem inim um and m axim um excursionsafter a m eal, these are still relevant clinical m arkers. Figure2 show sthem axim um and m inim um values aftereach m eal,w here once again the dotted lines represent the desi rabl e bounds. T he am ount of the insulin bolusand the corresponding insulin to carbohydrate ratios are show n in figures 3 and 4, respectively.T he insulin to carbohydrate ratio is w hat the patients and physicians use to calculate their insulin requirem ents for a given m eal; this show s clearly that the algorithm converges to the idealratio.It is im portant to note that although in this case they converge to approxim ately the sam e value,it is not necessarily the case in real life,asinsulin sensitivity hasa circadian variation w hich is not captured by the sim ulation m odel used.
C ONC LUSIONS
T he f easibility of using run-to-run control to determ ine the optim al insulin bolus dose and tim ing wasshow n by Zisser et al. (2005) ,butsom e hurdles w ere identified. C hanging the tim ing of the insulin bolus was one ofthem ,w hich coupled w ith the sm all di erence it m akes w hen using m onom eric insulin,itwas decided to keep itfixed to coincide w ith the beginning of the m eal.T he second w as the requirem ent that blood glucose m easurem ents be taken at 60 and 90 m inutes; besidesim posing additionalburden on the patient to keep close track of tim e after a m eal, it also m eant that w hen the patient m issed these tim e points the algorithm could no longer m ake a correction for the dosing the follow ing day.
W e have proposed a new perform ance m easure, w hich gives the patient the freedom of taking post-prandialglucosem easurem entsattim esthat are m ore flexible and do not require them to becom eslavesto theclock.W ehaveshow n thateven w ith this variation in the tim ing,the controller is able to converge w ithin a couple ofdays,significantly im proving the degree ofglycem ic control.
Further sim ulation studies m ust be done to incorporate other sources ofvariability that are expected, including m easurem ent noise, m ism atch between the estim ated carbohydrate content of the m eal and the actual value, and variation in the tim ing and carbohydrate contentofthe m eals. Initialresults (not show n) are quite encouraging. W e are currently undertaking a robustness analysis that takes into account allofthese sources of uncertainty. 
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